FDA | What's New
Follow
2025 | Public Meeting on the Reauthorization of Generic Drug User Fee Amendments (GDUFA) - 07/11/2025
FDA is announcing a public meeting to discuss proposed recommendations for the reauthorization of the Generic Drug User Fee Amendments for fiscal years 2028 through 2032.